Viewing StudyNCT00243568



Ignite Creation Date: 2024-05-05 @ 12:06 PM
Last Modification Date: 2024-10-26 @ 9:20 AM
Study NCT ID: NCT00243568
Status: WITHDRAWN
Last Update Posted: 2019-09-12
First Post: 2005-10-20

Brief Title: Vicriviroc a CCR5 Inhibitor Added to an Optimized Antiretroviral Therapy for Previously Treated HIV VICTOR-E2 Study P04285
Sponsor: Merck Sharp Dohme LLC
Organization: Merck Sharp Dohme LLC

Conditions & Keywords Data

Conditions:
Name
Acquired Immunodeficiency Syndrome
HIV Infections
Keywords:
Name View
treatment-experienced View
HIV Infections View
Acquired Immunodeficiency Syndrome View
CCR5CXCR4 mixed tropism View
R5X4 mixed tropism View
CCR5 inhibitor View
vicriviroc View